Postdoc: Bioconjugation Chemistry for Cancer Nanocarriers

Leiden University; Netherlands; On-site; EUR 41,000 - 64,000; Full time

Benefits offered by this job

Holiday allowance 8%

End-of-year bonus 8.3%

Training and career development

Dual career program

Tax break for international hires

Job summary

Leiden University invites applications for a postdoctoral researcher in bioconjugation for oncology nanocarriers. You will develop new conjugation strategies for cytotoxic agents on polymers and nanocarriers, focusing on robust, scalable chemistry and preparative synthesis with gram-scale potential.

Based in the Leiden Academic Centre for Drug Research, this full-time position is initially one year with possible extension.

Qualifications

• PhD in synthetic organic chemistry or closely related field.
• Strong experience in bioconjugation chemistry, ideally with cytotoxic or bioactive molecules.
• Hands-on preparative synthesis experience and scaling up to gram-scale.
• Enjoys working in a multidisciplinary team spanning chemistry, biology, and materials science.
• Motivated by research combining fundamental science with translational impact.

Responsibilities

• Develop new conjugation strategies for cytotoxic anticancer agents and other bioactive molecules on polymers and nanocarriers.
• Focus on chemistry that is robust, reproducible, and scalable.
• Scale up conjugation reactions to multigram-scale.
• Collaborate with chemists, cell biologists, microbiologists, and materials scientists across the project.

Skills

Bioconjugation chemistry

Preparative synthesis

Gram-scale scaling

Multidisciplinary collaboration

Translational research mindset

Education

PhD in synthetic organic chemistry

Job description

Leiden University invites applications for a postdoctoral researcher in bioconjugation for oncology nanocarriers. You will develop new conjugation strategies for cytotoxic agents on polymers and nanocarriers, focusing on robust, scalable chemistry and preparative synthesis with gram-scale potential.

Based in the Leiden Academic Centre for Drug Research, this full-time position is initially one year with possible extension.